South Korea’s Disease Control and Prevention Agency, in partnership with the National Medical Center, is organizing two major international symposia aimed at enhancing the nation’s infectious disease response. The events are part of ongoing efforts to build a robust research and medical infrastructure, supported by significant philanthropic contributions from the late Chairman Lee Kun-hee’s family. The symposia focus on integrating research, medical response, and artificial intelligence (AI) to create a comprehensive infectious disease management system. These initiatives align with national policy goals to reduce regional disparities, expand essential medical services, and strengthen public healthcare.
The symposia will impact a wide range of stakeholders, including researchers, healthcare professionals, government officials, and international organizations. On March 26, the LISID symposium will highlight clinical research and medical response strategies, sharing key achievements from the Infectious Disease Overcoming Research Capacity Enhancement Project. On March 27, the IDRIC symposium will emphasize AI-based rapid response technology development, fostering international cooperation and establishing South Korea as a hub for infectious disease research. The events are jointly hosted by the National Medical Center and the National Institute of Infectious Diseases, with the International Vaccine Institute as a partner.
Both symposia will be held at JW Marriott Dongdaemun Square Seoul, with live streaming and real-time Q&A available through official websites. The LISID symposium is the second of its kind, continuing efforts initiated by a KRW 7 trillion donation, which allocated KRW 5 trillion for hospital construction, KRW 1 trillion for research infrastructure, and KRW 1 trillion for research capacity enhancement. The IDRIC symposium, now in its fourth year, aims to strengthen international collaboration and accelerate vaccine and treatment development using AI. Pre-registration and access to materials are facilitated online, ensuring broad participation and transparency.
Frequently asked questions include: What is the purpose of these symposia? The events aim to share research achievements, build collaborative networks, and discuss strategies for national and global infectious disease response. Who can participate? Experts from academia, industry, government, and international organizations are invited, with online access available for broader engagement. How will these initiatives impact public health? By integrating clinical research, medical response, and AI technology, South Korea seeks to establish a sustainable system for rapid response to future pandemics and strengthen its role in global health security.
South Korea’s coordinated hosting of international symposia reflects a strategic investment in infectious disease preparedness. The integration of clinical research, medical response, and AI technology, backed by significant philanthropic and governmental support, is poised to strengthen both national and global health security. The transparent, collaborative approach—facilitated by online participation and resource sharing—sets a benchmark for effective public health policy. These efforts are likely to yield sustainable improvements in rapid response infrastructure and international cooperation.